STAAR Surgical Company (STAA) Tuesday announced partnership with ophthalmology group, SharpeVision to provide EVO ICL lenses to all qualified patients in SharpeVision clinics.
STAAR Surgical makes the EVO family of Implantable Collamer Lenses (EVO ICL) for myopia, astigmatism and presbyopia.
At the initial stage, 1,000 ICL units per annum will be purchased, about 25% of SharpeVision's refractive procedure volume.
The companies also plan to increase awareness of EVO ICL by marketing and education activities.
"Given the outstanding outcomes, EVO ICL is now my first recommendation for patients seeking refractive vision correction," said Matthew Sharpe, founder and surgeon, SharpeVision.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.